Basic pharmacokinetic parameters for ALX-0081 after single IV administration to cynomolgus monkeys
Dose, mg/kg . | AUCinfd, h × kg/mL . | CL, mL/h/kg . | t1/2 terminal, h . |
---|---|---|---|
0.02 | 0.559 ± 0.192 | 1.97 ± 0.65 | 17.0 ± 6.6 |
0.40 | 0.085 ± 0.025 | 13.24 ± 6.11 | 18.9 ± 6.1 |
8.00* | 0.016 ± 0.004 | 65.69 ± 15.31 | 30.2 ± 5.3 |
Dose, mg/kg . | AUCinfd, h × kg/mL . | CL, mL/h/kg . | t1/2 terminal, h . |
---|---|---|---|
0.02 | 0.559 ± 0.192 | 1.97 ± 0.65 | 17.0 ± 6.6 |
0.40 | 0.085 ± 0.025 | 13.24 ± 6.11 | 18.9 ± 6.1 |
8.00* | 0.016 ± 0.004 | 65.69 ± 15.31 | 30.2 ± 5.3 |
Mean ± SD, n = 6 per dose level. Increase of CL with dose is an artifact of the noncompartmental analysis.
AUCinf indicates area under the plasma concentration time curve, calculated from 0 to infinity; D, dose; and CL, clearance.
One animal was considered an outlier due to a nondecreasing profile and was therefore excluded from the analysis (n = 5).